Pursuant to the Company's Code of Conduct for Prevention of Insider Trading framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, Panacea Biotec has informed that the trading window of the Company shall remain closed for all the Designated Persons of the Company from April 01, 2023 till completion of 48 hours from the announcement to the Stock Exchanges regarding Audited financial results of the Company for the quarter and financial year ended March 31, 2023. The date of meeting of the Board of Directors to approve the Audited financial results of the Company for the quarter and financial year ended March 31, 2023, shall be informed in due course.
The above information is a part of company’s filings submitted to BSE.
